The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients
Abstract
Posttransplant lymphoproliferative disease (PTLD) is a frequent and severe Epstein-Barr virus (EBV)–associated complication in transplantation recipients that is caused by iatrogenic suppression of T-cell function. The diagnostic value of weekly EBV DNA load monitoring was investigated in prospectively collected unfractionated whole blood and serum samples of lung transplantation (LTx) recipients with and without PTLD. In PTLD patients, 78% of tested whole blood samples were above the cut-off value of quantitative competitive polymerase chain reaction (Q-PCR) (greater than 2000 EBV DNA copies per mL blood), with the majority of patients having high viral loads before and at PTLD diagnosis. Especially in a primary EBV-infected patient and in patients with conversion of immunosuppressive treatment, rapid increases in peripheral blood EBV DNA load diagnosed and predicted PTLD. In non-PTLD transplantation recipients, only 3.4% of the whole blood samples was above the cut-off value (P < .0001) despite heavy immune suppression and cytomegalovirus (CMV)-related disease. These findings illustrate the clinical importance of frequent EBV DNA load monitoring in LTx recipients. The increased EBV DNA loads in PTLD patients were restricted to the cellular blood compartment, as parallel serum samples were all below cut-off value, which indicates absence of lytic viral replication. EBV+ cells in PTLD patients have a very short doubling time, which can be as low as 56 hours, thereby creating the need for high screening frequency in high-risk patients. Furthermore, it is shown that EBV and CMV can reactivate independently in LTx recipients and that EBV DNA load monitoring may be useful in discriminating PTLD from rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid and simple method for purification of nucleic acids
Boom, R., Sol, C. J., Salimans, M. M., Jansen, C. L., Wertheim-van Dillen, P. M., & van der Noordaa, J. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.3.495-503.1990 · Cited by 5,266
Avoiding false positives with PCR
Kwok, S., & Higuchi, R. (1989) · Nature · doi:10.1038/339237a0 · Cited by 3,441
Rickinson, A. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,179
de Roda Husman, A.-M., Walboomers, J. M. M., van den Brule, A. J. C., Meijer, C. J. L. M., & Snijders, P. J. F. (1995) · Journal of General Virology · doi:10.1099/0022-1317-76-4-1057 · Cited by 1,283
Self-citationNalesnik, M. A., Jaffe, R., Starzl, T. E., et al. (1988) · PubMed · Cited by 700
EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
Paya, C. V., Fung, J. J., Nalesnik, M. A., Kieff, E., Green, M., Gores, G., Habermann, T. M., Wiesner, R. H., Swinnen, L. J., Woodle, E. S., et al. (1999) · Transplantation · doi:10.1097/00007890-199911270-00015 · Cited by 533
Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop.
Harris, N. L., Ferry, J. A., & Swerdlow, S. H. (1997) · PubMed · Cited by 344
Rowe, D. T., Qu, L., Reyes, J., Jabbour, N., Yunis, E., Putnam, P., Todo, S., & Green, M. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.6.1612-1615.1997 · Cited by 301
Savoie, A., Perpete, C., Carpentier, L., Joncas, J. H., & Alfieri, C. (1994) · Blood · doi:10.1182/blood.v83.9.2715.2715 · Cited by 264
Wagner, H. J., Bein, G., Bitsch, A., & Kirchner, H. (1992) · Journal of Clinical Microbiology · doi:10.1128/jcm.30.11.2826-2829.1992 · Cited by 133
Cited by
Post-Transplant Lymphoproliferative Disorders
Gottschalk, S., Rooney, C. M., & Heslop, H. E. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104727 · Cited by 489
Post-Transplantation Lymphoproliferative Disorders in Adults
Dierickx, D., & Habermann, T. M. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1702693 · Cited by 481
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
Annese, V., Beaugerie, L., Egan, L., Biancone, L., Bolling, C., Brandts, C., Dierickx, D., Dummer, R., Fiorino, G., Gornet, J. M., et al. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv141 · Cited by 428
Styczynski, J., van der Velden, W., Fox, C. P., Engelhard, D., de la Camara, R., Cordonnier, C., Ljungman, P., & on behalf of the Sixth European Conference on Infections in Leukemia, A. J. V. O. T. I. D. W. P. O. T. E. S. O. B. A. M. T. (.-I. (2016) · Haematologica · doi:10.3324/haematol.2016.144428 · Cited by 408
Teramura, T., Tabata, Y., Yagi, T., Morimoto, A., Hibi, S., & Imashuku, S. (2002) · Leukemia & Lymphoma · doi:10.1080/10428190210176 · Cited by 61
Metadata
- Authors
- Stevens, S. J. C., Verschuuren, E. A. M., Pronk, I., van der Bij, W., Harmsen, M. C., The, T. H., Meijer, C. J. L. M., van den Brule, A. J. C., & Middeldorp, J. M.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2001-03-01
- Volume
- 97
- Issue
- 5
- Pages
- 1165-1171
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W2009628438
- Cited by
- 329
- References
- 13
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. https://app.cochat.ai/papers/10.1182/blood.v97.5.1165
- The paper
- Stevens, S. J. C., Verschuuren, E. A. M., Pronk, I., van der Bij, W., Harmsen, M. C., The, T. H., Meijer, C. J. L. M., van den Brule, A. J. C., & Middeldorp, J. M. (2001). Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. Blood. https://doi.org/10.1182/blood.v97.5.1165
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.